GlassScriptPhysician profile
Timothy J Nicholson
NPI 1013091941
$559.24
in general payments reported to CMS, 2019-2025
11 companies · $129 in 2025
The $129 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30.66 · 2021: $54.26 · 2022: $127 · 2023: $129 · 2024: $90.15 · 2025: $129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $348.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $347.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $179.22 | 2021-2024 | |
| Glaxosmithkline, LLC. | $128.84 | 2019-2025 | Shingrix, Arexvy, Bexsero |
| Novo Nordisk INC | $74.93 | 2019-2025 | Wegovy, Ozempic |
| Supernus Pharmaceuticals, INC. | $35.24 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $29.49 | 2022 | |
| Inspire Medical Systems, INC. | $23.83 | 2025 | Inspire |
| Phathom Pharmaceuticals, INC. | $18.88 | 2025 | Voquezna |
| Abbott Laboratories | $18.79 | 2024 | Freestyle Libre 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.04 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $17.03 | 2025 | Airsupra |
| Alnylam Pharmaceuticals INC. | $14.95 | 2024 | Givlaari |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Nicholson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.